EMFOSIK-25
March 28, 2026
EMFOSIK-L 10/5
March 28, 2026
EMFOSIK-M 12.5/500
₹3,550.00
Composition:
Empagliflozin 12.5 mg, Metformin 500 mg
Packaging Detail:
10 x 10
Description
A fixed-dose combination tablet for type 2 diabetes. It pairs Empagliflozin (an SGLT2 inhibitor) with Metformin (which reduces glucose production in the liver and improves insulin sensitivity) for comprehensive glycemic control.
Indications
Indications
-
Type 2 diabetes mellitus when monotherapy with either agent is inadequate.
-
As an adjunct to diet and exercise to improve glycemic control.
Side Effects
Side Effects
-
Genital fungal infections.
-
Urinary tract infections.
-
Gastrointestinal issues (nausea, diarrhea) from Metformin.
-
Increased urination and dehydration.
-
Rare risk of lactic acidosis (with Metformin) and ketoacidosis.
Reviews 0
Related products
-
CEFIMOX-200
₹1,193.00 -
ACEFOX-SP
₹955.00 -
AZIMEL-500
₹1,320.00
Reviews
There are no reviews yet.